Can management of the components of metabolic syndrome modify the course of chronic kidney disease?
Yaeni Kim, Cheol Whee Park
Kidney Res Clin Pract. 2020;39(2):118-120.   Published online 2020 Jun 30     DOI: https://doi.org/10.23876/j.krcp.20.066
Citations to this article as recorded by Crossref logo
Predictive Effect of System Inflammation Response Index for Progression of Chronic Kidney Disease in Non-Dialyzing Patient
Leile Tang, Ying Deng, Jiahui Lai, Xinghua Guo, Peijia Liu, Shaomin Li, Xun Liu
Journal of Inflammation Research.2023; Volume 16: 5273.     CrossRef
Association between recovery/occurrence of metabolic syndrome and rapid estimated glomerular filtration rate decline in middle-aged and older populations: evidence from the China Health and Retirement Longitudinal Study
Peijia Liu, Leile Tang, Jia Fang, Chaojin Chen, Xun Liu
BMJ Open.2022; 12(10): e059504.     CrossRef
Nutrition and quality of life in chronic kidney disease patients: a practical approach for salt restriction
Kunitoshi Iseki
Kidney Research and Clinical Practice.2022; 41(6): 657.     CrossRef
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12
Giacomo Zoppini, Maddalena Trombetta, Ilaria Pastore, Corinna Brangani, Vittorio Cacciatori, Carlo Negri, Fabrizia Perrone, Isabella Pichiri, Vincenzo Stoico, Daniela Travia, Elisabetta Rinaldi, Giuliana Da Prato, Cristina Bittante, Riccardo C. Bonadonna,
Diabetes Research and Clinical Practice.2021; 175: 108778.     CrossRef
Renal effects of uric acid: hyperuricemia and hypouricemia
Jung Hwan Park, Yong-Il Jo, Jong-Ho Lee
The Korean Journal of Internal Medicine.2020; 35(6): 1291.     CrossRef